197 related articles for article (PubMed ID: 9798069)
1. Glutamatergic neurotransmission involves structural and clinical deficits of schizophrenia.
Tsai G; van Kammen DP; Chen S; Kelley ME; Grier A; Coyle JT
Biol Psychiatry; 1998 Oct; 44(8):667-74. PubMed ID: 9798069
[TBL] [Abstract][Full Text] [Related]
2. [Glutamatergic neurotransmission in schizophrenics].
Bleich S; Bleich K; Wiltfang J; Maler JM; Kornhuber J
Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S56-61. PubMed ID: 11533851
[TBL] [Abstract][Full Text] [Related]
3. Hypothesis: minimal changes in neural transmission in schizophrenia: decreased glutamatergic and GABAergic functions in the prefrontal cortex.
Ohnuma T; Suzuki T; Arai H
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):889-94. PubMed ID: 15949884
[TBL] [Abstract][Full Text] [Related]
4. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
Deakin FW; Simpson MD; Slater P; Hellewell JS
J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
[TBL] [Abstract][Full Text] [Related]
5. Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
Pietraszek M
Pol J Pharmacol; 2003; 55(2):133-54. PubMed ID: 12926541
[TBL] [Abstract][Full Text] [Related]
6. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
7. Glutamatergic aspects of schizophrenia.
Tamminga C
Br J Psychiatry Suppl; 1999; (37):12-5. PubMed ID: 10211134
[TBL] [Abstract][Full Text] [Related]
8. [Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].
Mechri A; Saoud M; Khiari G; d'Amato T; Dalery J; Gaha L
Encephale; 2001; 27(1):53-9. PubMed ID: 11294039
[TBL] [Abstract][Full Text] [Related]
9. The glutamatergic dysfunction hypothesis for schizophrenia.
Coyle JT
Harv Rev Psychiatry; 1996; 3(5):241-53. PubMed ID: 9384954
[TBL] [Abstract][Full Text] [Related]
10. Down-Regulation of Hippocampal Genes Regulating Dopaminergic, GABAergic, and Glutamatergic Function Following Combined Neonatal Phencyclidine and Post-Weaning Social Isolation of Rats as a Neurodevelopmental Model for Schizophrenia.
Gaskin PL; Toledo-Rodriguez M; Alexander SP; Fone KC
Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27382048
[TBL] [Abstract][Full Text] [Related]
11. [Role of astrocytes in alterations of glutamatergic neurotransmission in schizophrenia].
Kolomeets NS
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):110-117. PubMed ID: 25945378
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia.
Goff DC; Coyle JT
Am J Psychiatry; 2001 Sep; 158(9):1367-77. PubMed ID: 11532718
[TBL] [Abstract][Full Text] [Related]
13. Schizophrenia and glutamatergic transmission.
Tamminga CA
Crit Rev Neurobiol; 1998; 12(1-2):21-36. PubMed ID: 9444480
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of central neurotransmission systems in schizophrenia].
Martres MP
Therapie; 2008; 63(3):177-85. PubMed ID: 18718209
[TBL] [Abstract][Full Text] [Related]
15. Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation.
Salavati B; Rajji TK; Price R; Sun Y; Graff-Guerrero A; Daskalakis ZJ
Schizophr Bull; 2015 Jan; 41(1):44-56. PubMed ID: 25249654
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
Heresco-Levy U
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
[TBL] [Abstract][Full Text] [Related]
17. Phencyclidine animal models of schizophrenia: approaches from abnormality of glutamatergic neurotransmission and neurodevelopment.
Mouri A; Noda Y; Enomoto T; Nabeshima T
Neurochem Int; 2007; 51(2-4):173-84. PubMed ID: 17669558
[TBL] [Abstract][Full Text] [Related]
18. Animal model of schizophrenia: dysfunction of NMDA receptor-signaling in mice following withdrawal from repeated administration of phencyclidine.
Nabeshima T; Mouri A; Murai R; Noda Y
Ann N Y Acad Sci; 2006 Nov; 1086():160-8. PubMed ID: 17185514
[TBL] [Abstract][Full Text] [Related]
19. Phenomenology, aetiology and treatment of schizophrenia.
Javitt DC
Novartis Found Symp; 2008; 289():4-16; discussion 17-22, 87-93. PubMed ID: 18497092
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic mechanisms in schizophrenia.
Tsai G; Coyle JT
Annu Rev Pharmacol Toxicol; 2002; 42():165-79. PubMed ID: 11807169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
